Skip to content

Source filing unavailable

Q2 2017 · —
Revenue$15.36Mno prior Q2 2016 on file+3.4% vs Q1 2017
Net Income-$1.81Mno prior Q2 2016 on fileN/M vs Q1 2017
EPS Diluted-$4.07no prior Q2 2016 on fileN/M vs Q1 2017
Margins · derived
Net margin-11.8%

What the release said

No earnings release is on file for this quarter. Its figures came with the 10-Q.

Same quarter

no prior Q2 2016 on file

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Sutro Biopharma, Inc. · CIK 1382101 · Engraved from SEC EDGAR